Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest update is out from AdAlta Ltd. ( (AU:1AD) ).
AdAlta Limited has issued 41,666,667 fully paid ordinary shares to NLSC, LLC as part of its funding arrangements, with each share priced at $0.0018. This move is part of the company’s strategic financial management, ensuring compliance with relevant corporate regulations, and it highlights AdAlta’s ongoing efforts to secure necessary funding for its operations.
More about AdAlta Ltd.
AdAlta Limited is a biotechnology company that focuses on developing innovative therapies using its proprietary i-body technology. The company primarily operates in the healthcare sector, aiming to address unmet medical needs through its unique platform.
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$3.34M
Learn more about 1AD stock on TipRanks’ Stock Analysis page.